Empadiance 10 is an oral antidiabetic medication containing **Empagliflozin**, a selective **SGLT2 inhibitor**, produced by Alhavi Pharmaceutical.
It is used to manage blood glucose levels in adults with type 2 diabetes mellitus by inhibiting glucose reabsorption in the kidneys, resulting in the excretion of excess glucose through urine.
This helps reduce blood sugar levels, while also supporting weight and blood pressure control.
Empadiance is available in **10 mg** and **25 mg** strengths.
Empadiance 10 (Empagliflozin)
Dosage form: Tablet
Empadiance 10 is indicated for:
• Control of blood glucose levels in adults with type 2 diabetes mellitus (as monotherapy or in combination with other antidiabetic medications such as Metformin or Insulin)
• Reduction of cardiovascular risk in diabetic patients with a history of heart disease
By promoting urinary glucose excretion, Empadiance lowers blood glucose and provides additional metabolic benefits.
• Recommended dose: **10 mg once daily**
• May be increased to **25 mg once daily** as directed by the physician
• Can be taken in the morning, **with or without food**
• Swallow the tablet whole with water — do not crush or chew
• Maintain adequate hydration during treatment
• Use under medical supervision, particularly in patients with kidney or liver impairment